WSMD2017 Final Program

Aula Magna Fratelli Pontecorvo
University of Pisa
Largo Bruno Pontecorvo, 3
I-56127 Pisa

15 June 2017

8.00-8.45   Registration

8.45-9.00   Alberto Del Guerra, University of Pisa (Italy)
Welcome and introduction

9.00-10.00 Session 1 - Mental disorders: where do we stand?
Chairpersons: Liliana Dell'Osso, University of Pisa (Italy) and Alberto Del Guerra, University of Pisa (Italy)

9.00-9.30 Silvana Galderisi, University of Campania “Luigi Vanvitelli” (Italy)
Current Trends in diagnosis and treatment of mental disorders

9.30-10.00 Lara Passante, EU-DG for Research and Innovation and François Junique, EU-DG CONNECT
The FP7 and Horizon2020 funding strategy of projects on mental disorders

10:00-10:30 Coffee break (on site)

10.30-13.30 Session 2 - Status of the FP7 and Horizon 2020 funded projects on mental disorders
Chairpersons: Silvana Galderisi, University of Campania “Luigi Vanvitelli” (Italy) and Ubaldo Bonuccelli, University of Pisa (Italy)

10.30-11.00 Inge Winter-van Rossum, University of Utrecht (The Netherlands)
OPTIMISE: Optimization of Treatment and Management of Schizophrenia in Europe

11.00-11.30 Nikolaos Koutsouleris, Ludwig-Maximilians-Universität München (Germany)
PRONIA: Personalised Prognostic Tools for Early Psychosis Management

11.30-12.00 Philip McGuire, King's College London (UK)
PSYSCAN: Translating neuroimaging findings from research into clinical practice

12.00-12.30 Alberto Del Guerra, University of Pisa (Italy)
TRIMAGE: A dedicated trimodality (PET/MR/EEG) imaging tool for schizophrenia

12.30-13.00 Jose Benlloch, University of Valencia (Spain)
MINDVIEW: Multimodal Imaging of Neurological Disorders

13.00-13.30 Luc Truyen, Johnson & Johnson (USA)
The view of the Pharmaceutical European Industry in Neuroscience

13:30-14:30 Lunch Break (on site)

14.30 -16.30 Session 3 - Status of the FP7 and Horizon 2020 funded projects on mental disorders (continued)
Chairpersons: Paolo Brambilla, University of Milano (Italy) and Celso Arango, Gregorio Marañón Hospital (Spain)

14.30-15.00 Giuseppe Blasi, University of Bari (Italy)
IMAGEMEND: IMAging GEnetics for MENtal Disorders

15.00-15.30 David Linden, Cardiff University (UK)
BRAINTRAIN: Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders

15.30 -16.00 Georg Winterer, Charité – Universitätsmedizin Berlin (Germany)
BIOCOG: Biomarker Development for Postoperative Cognitive Impairment in the Elderly

16.00-16.30 Matej Oresic, University of Turku (Finland)
METSY: Neuroimaging platform for characterisation of metabolic co-morbidities in psychotic disorders

16.30-17.00 Klaus P. Ebmeier, University of Oxford (UK)
LIFEBRAIN: Healthy minds from 0-100 years: Optimising the use of European brain imaging cohorts

17:00-17:30 Coffee break (on site)

17.30-19.00 Session 4 - The IMI contribution in Brain studies
Chairpersons: Carlo Altamura, University of Milano (Italy) and Karsten Heekeren, University of Zürich (Switzerland)

17.30-18.00 Elisabetta Vaudano, IMI
The IMI consortium and the IMI funded projects in Central Nervous System (CNS)

18.00-18.30 Nikolay Manyakov, Janssen Pharmaceuticals (Belgium)
RADAR CNS: Use of Wearable Devices and Mobile Technology to Understand the Course of Brain Diseases

18.30-19.00 Celso Arango, Gregorio Marañón Hospital (Spain)
PRISM: Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in Alzheimer’s Disease, Schizophrenia, and Mayor Depression

19.00 Adjourn

16 June 2017

8.30-11.00 Session 5 - Neurodegenerative diseases and the Human Brain Project
Chairpersons: Giovanni Cioni, University of Pisa (Italy) and Adriana Maggi, University of Milano (Italy)

8.30-9.00 Adriana Maggi, University of Milano (Italy)
Alzheimer’s Disease: Diagnosis, Prognosis and Current Therapy

9.00-9.30 Claudio Franceschi, University of Bologna (Italy)
Parkinson disease within the conceptual framework of the new Geroscience

9.30-10.00 Mirco Cosottini, University of Pisa (Italy)
7T MRI neuroimaging for neurodegenerative disorders

10.00-10.30 Sabina Berretta, Harvard Medical School (USA) 
Mortui vivos docent: Recent Advances on the Involvement of Synaptic Pathology in Schizophrenia

10.30-11.00 Jan Bjaalie, University of Oslo (Norway)
The Human Brain Project: a Platform for Big-Data Neuroscience

11:00-11:30 Coffee break on site

11.30-13.30 Session 6 - Panel discussion Future Coordination and integration of the results of the FP7 and IMI projects and HBP on Schizophrenia and other Mental Disorders

Participants: Lara Passante (EC, Belgium), Elisabetta Vaudano (IMI, Belgium), Jan Bjaalie (University of Oslo, Norway), Nikolaos Koutsouleris (LMU München, Germany)
Moderator: Marlies Dorlöchter, DLR (Germany)

13.30 Closure
Alberto Del Guerra, University of Pisa (Italy)

Lunch (on site)